NantHealth (NH) Stock Price, News & Analysis

Company Overview

NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.

Key Stats

• Today's Range: $0.0120 to $0.0120
• 50-Day Range: $0.00 to $0.05
• 52-Week Range: $1.24 to $9.75
• Volume: 3 shs
• Average Volume: 38,073 shs
• Market Capitalization: $92.44 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NantHealth Stock Analysis - MarketRank™

NantHealth scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for NantHealth.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of NantHealth is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of NantHealth is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for NH.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

NantHealth does not currently pay a dividend.

Dividend Growth

NantHealth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.3 / 5
• Environmental Score: -0.69

Short Interest

There is no current short interest data available for NH.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for NantHealth this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, NantHealth insiders have not sold or bought any company stock.

Percentage Held by Insiders

61.30% of the stock of NantHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 4.50% of the stock of NantHealth is held by institutions.

NH Stock Analysis - Frequently Asked Questions

How have NH shares performed this year?

NantHealth's stock was trading at $0.0031 at the beginning of 2025. Since then, NH shares have increased by 287.1% and is now trading at $0.0120.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) released its quarterly earnings results on Thursday, November, 4th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.02. The company had revenue of $14.36 million for the quarter, compared to analysts' expectations of $17.70 million.

When did NantHealth IPO?

NantHealth (NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

How do I buy shares of NantHealth?

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NantHealth investors own include NVIDIA (NVDA), Sorrento Therapeutics (SRNE), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Gilead Sciences (GILD).

Company Calendar

• Last Earnings: 11/04/2021
• Today: 8/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Data processing & preparation
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:NH
• Previous Symbol: NYSE:NH
• CIK: 1566469
• Web: www.nanthealth.com
• Phone: (855) 949-6268
• Fax: N/A
• Employees: 340
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($7.65)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$67.78 million
• Net Margins: -94.67%
• Pretax Margin: -95.06%
• Return on Equity: N/A
• Return on Assets: -39.82%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.64
• Quick Ratio: 0.64

Sales & Book Value

• Annual Sales: $67.68 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($30.72) per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 7,703,000
• Free Float: 2,981,000
• Market Cap: $92.44 thousand
• Optionable: Not Optionable
• Beta: 1.82